Hainan Shuangcheng Pharmaceuticals Co., Ltd. drugs

3 results

  • eptifibatide

    (Eptifibatide)
    Hainan Shuangcheng Pharmaceuticals Co., Ltd.
    Eptifibatide injection is indicated to reduce the risk of death or new myocardial infarction in patients with acute coronary syndrome (ACS) and to decrease the rate of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI), including those receiving intracoronary stenting.
    Medication Details
    Drug Interactions

  • octreotide acetate

    (octreotide acetate)
    Hainan Shuangcheng Pharmaceuticals Co., Ltd.
    Octreotide acetate injection is indicated for reducing growth hormone and IGF-1 levels in acromegaly, treating severe diarrhea and flushing from metastatic carcinoid tumors, and managing profuse watery diarrhea from vasoactive intestinal peptide tumors (VIPomas). Clinical trials did not demonstrate improvements in tumor size or growth rate.
    Medication Details
    Drug Interactions